Clinical
Research Articles >>

ACT: Actions with the CONTOUR^® Blood Glucose Meter and Behaviors in Frequent Testers

Bayer's CONTOUR^® meter:  Easy to use, now shown to help patients achieve success with mealtime testing. ^1,2
 

In the ACT* Study, use of the optional tracking features was shown to^†:

• Result in more actionable testing, including:
  • Postprandial testing¹
  • Paired pre- and postprandial testing¹
• Help patients gain insights that lead to:
  • Increased understanding of self-management²
  • More confidence in making adjustments to diet² and exercise³

<sup>*Actions With the CONTOUR® Blood Glucose Meter and Behaviors in Frequent Testers.
†Compared with patients using standard features.
‡Bayer’s CONTOUR® test strips with GDH-FAD chemistry cross-react with xylose. Do not use CONTOUR® test strips during or shortly after a xylose absorption test.

REFERENCES: 1. Bode B, Bergenstal R, Tamler R, et al. ACT: Actions with the CONTOUR® blood glucose meter and behaviours in frequent testers. Poster presented at: 46th Annual Meeting of the European Association for the Study of Diabetes (EASD); September 20-24, 2010; Stockholm, Sweden.
2. Kohut T, Stenger P, Schachner HC, et al. An information-motivation-behavioral skills analysis: participant perceptions, motivation to test, and glycemic control outcomes of frequent testers in the ACT trial. Poster presented at: 46th Annual Meeting of the European Association for the Study of Diabetes (EASD); September 20-24, 2010; Stockholm, Sweden.
3. Data on file, Bayer HealthCare Diabetes Care.</sup>